Rosati, Rayna <br/><br/>
Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  12 2018 
 - 6509-6522 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-18-0982  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Receptor Antagonists--chemistry<br/>Animals<br/>Antineoplastic Agents, Hormonal--chemistry<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Drug Discovery--methods<br/>Drug Screening Assays, Antitumor<br/>Gene Expression Profiling<br/>High-Throughput Screening Assays<br/>Humans<br/>Male<br/>Mice<br/>Promoter Regions, Genetic<br/>Prostatic Neoplasms--drug therapy<br/>Protein Binding<br/>Receptors, Androgen--metabolism<br/>Structure-Activity Relationship<br/>Xenograft Model Antitumor Assays<br/>ets-Domain Protein Elk-1--metabolism